Eterna Therapeutics Launches Research To Evaluate ERNA-101's Ability To Induce And Modulate Antitumor Immunity In Ovarian And Breast Cancer Models
Eterna Therapeutics Launches Research To Evaluate ERNA-101's Ability To Induce And Modulate Antitumor Immunity In Ovarian And Breast Cancer Models
Eterna Therapeutics啓動研究,評估ERNA-101在卵巢和乳腺癌模型中誘導和調節抗腫瘤免疫的能力
Eterna Therapeutics Launches Research To Evaluate ERNA-101's Ability To Induce And Modulate Antitumor Immunity In Ovarian And Breast Cancer Models
Eterna Therapeutics啓動研究,以評估ERNA-101在卵巢癌和乳腺癌模型中誘導和調節抗腫瘤免疫的能力